Key result
A rotating inotrope regimen including levosimendan was safe in 9 pediatric patients with decompensated heart failure, with 77.8% surviving to hospital discharge.
Case Report (n=9)
No
A rotating inotrope regimen including levosimendan was well tolerated and allowed survival to discharge or transplant in a small series of pediatric patients with severe decompensated heart failure.
Hypothesis-generating for rotating levosimendan regimens in pediatric decompensated HF; should not change practice without prospective data.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ryerson et al. (2010) conducted a case report in decompensated heart failure (n=9). Rotating inotrope regimen (levosimendan, dobutamine, milrinone) was evaluated on Survival to hospital discharge. A rotating inotrope regimen including levosimendan was safe in 9 pediatric patients with decompensated heart failure, with 77.8% surviving to hospital discharge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: